Gadoquatrane - a new tetrameric, high relaxivity, macrocyclic gadolinium-based contrast agent for MRI
08:00Jessica Lohrke, Berlin / DE
3
Radiomic and volumetric analysis on the accumulation of gadolinium in the basal nuclei: a pilot study
08:00Giorgio Piga, Sassari / IT
4
Detection rate of MR myelography without intrathecal gadolinium in patients with newly diagnosed spontaneous intracranial hypotension
08:00Dana Kim, Seoul / KR
5
Differences in gadolinium retention of macrocyclic MR contrast agents in a rat model of subtotal renal failure
08:00Roberta Bonafe, Colleretto Giacosa / IT
6
Clinical efficacy of reduced-dose gadobutrol vs standard-dose gadoterate in contrast-enhanced CNS imaging: an international, multicentre, prospective, cross-over trial (LEADER-75)